PTH [1–34] induced differentiation and mineralization of mandibular condylar cartilage

Intermittent Parathyroid Hormone (I-PTH) is the only FDA approved anabolic drug therapy available for the treatment of osteoporosis in males and postmenopausal females. The effects of I-PTH on the chondrogenic lineage of the mandibular condylar cartilage (MCC) are not well understood. To investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: O’ Brien, Mara Heather, Dutra, Eliane Hermes, Lima, Alexandro, Nanda, Ravindra, Yadav, Sumit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468307/
https://www.ncbi.nlm.nih.gov/pubmed/28607469
http://dx.doi.org/10.1038/s41598-017-03428-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468307/
https://www.ncbi.nlm.nih.gov/pubmed/28607469
http://dx.doi.org/10.1038/s41598-017-03428-y

Ejemplares similares